Passage Bio Stock Price on November 18, 2024
| PASG Stock | USD 0.61 0 0.33% |
Below is the normalized historical share price chart for Passage Bio extending back to February 28, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Passage Bio stands at 0.61, as last reported on the 19th of December, with the highest price reaching 0.61 and the lowest price hitting 0.61 during the day.
If you're considering investing in Passage Stock, it is important to understand the factors that can impact its price. Passage Bio appears to be extremely dangerous, given 3 months investment horizon. Passage Bio maintains Sharpe Ratio (i.e., Efficiency) of 0.0307, which implies the firm had a 0.0307% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Passage Bio, which you can use to evaluate the volatility of the company. Please evaluate Passage Bio's Risk Adjusted Performance of 0.0255, coefficient of variation of 4898.89, and Semi Deviation of 6.75 to confirm if our risk estimates are consistent with your expectations.
At this time, Passage Bio's Stock Based Compensation is most likely to increase significantly in the upcoming years. . At this time, Passage Bio's Price To Book Ratio is most likely to increase significantly in the upcoming years. The Passage Bio's current Price Fair Value is estimated to increase to 0.52, while Price To Operating Cash Flows Ratio is projected to decrease to (0.74). Passage Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of February 2020 | 200 Day MA 0.9478 | 50 Day MA 0.6548 | Beta 1.196 |
Passage |
Sharpe Ratio = 0.0307
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PASG | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.36 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.35 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Passage Bio is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Passage Bio by adding it to a well-diversified portfolio.
Price Book 0.5194 | Book Value 2.025 | Enterprise Value -21.2 M | Enterprise Value Ebitda 0.8725 | Shares Float 45.5 M |
Related Headline
Cabaletta Bio Headline on 18th of November 2024
Cabaletta Bio Presents Positive Clinical Safety and Efficacy... by finance.yahoo.com
CABA-201 safety profile suggests favorable risk-benefit with no CRS or ICANS in the majority of patients low-grade CRS in three of eight patients and one previously reported ICANS event Compelling clinical responses observed in lupus and myositis patients with up to six months of follow-up first SSc patient demonstrated an emerging, drug-free clinical response All eight patients with active, refractory autoimmune disease discontinued all immunosuppressants prior to CABA-201 infusion
Passage Bio Valuation on November 18, 2024
It is possible to determine the worth of Passage Bio on a given historical date. On November 18, 2024 Passage was worth 0.52 at the beginning of the trading date compared to the closed value of 0.47. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Passage Bio stock. Still, in general, we apply an absolute valuation method to find Passage Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Passage Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Passage Bio's related companies.
| Open | High | Low | Close | Volume | |
| 0.59 | 0.61 | 0.49 | 0.52 | 575,292 | |
11/18/2024 | 0.52 | 0.52 | 0.47 | 0.47 | 394,482 |
| 0.47 | 0.49 | 0.45 | 0.48 | 232,467 |
| Backtest Passage Bio | | | Passage Bio History | | | Passage Bio Valuation | Previous | Next |
Passage Bio Trading Date Momentum on November 18, 2024
| On November 19 2024 Passage Bio was traded for 0.48 at the closing time. The top price for the day was 0.49 and the lowest listed price was 0.45 . The trading volume for the day was 232.5 K. The trading history from November 19, 2024 was a factor to the next trading day price rise. The trading delta at closing time against the next closing price was 2.13% . The trading delta at closing time against the current closing price is 65.96% . |
Passage Bio Fundamentals Correlations and Trends
By evaluating Passage Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Passage Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Passage financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Passage Bio Stock history
Passage Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Passage is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Passage Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Passage Bio stock prices may prove useful in developing a viable investing in Passage Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 54.7 M | 49.7 M | |
| Net Loss | -122.5 M | -128.6 M |
Passage Bio Quarterly Net Working Capital |
|
Passage Bio Stock Technical Analysis
Passage Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Passage Bio Period Price Range
Low | December 19, 2024
| High |
0.00 | 0.00 |
Passage Bio cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Passage Bio December 19, 2024 Market Strength
Market strength indicators help investors to evaluate how Passage Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Passage Bio shares will generate the highest return on investment. By undertsting and applying Passage Bio stock market strength indicators, traders can identify Passage Bio entry and exit signals to maximize returns
Passage Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Passage Bio's price direction in advance. Along with the technical and fundamental analysis of Passage Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Passage to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0255 | |||
| Jensen Alpha | 0.149 | |||
| Total Risk Alpha | (0.05) | |||
| Sortino Ratio | 0.026 | |||
| Treynor Ratio | 0.0611 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Passage Stock analysis
When running Passage Bio's price analysis, check to measure Passage Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Passage Bio is operating at the current time. Most of Passage Bio's value examination focuses on studying past and present price action to predict the probability of Passage Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Passage Bio's price. Additionally, you may evaluate how the addition of Passage Bio to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |